Aref Al-Kali
@AlkaliDr
Hematologist focused on myeloid diseases. views are mine
Hematologists are problem-solvers. I’m proud to support the #Fight4Hematology to fund bold research and training that pushes our field forward. donate.hematology.org/s/
When a peripheral blood smear adds more ??? to a puzzling case 🤔 #hematology 🩸 🔬 ?
We’re in this together. Let’s keep hematology moving forward. #Fight4Hematology Donate now. donate.hematology.org/s/
At some point, someone invested in us. Now it’s our turn. Join me in supporting the #Fight4Hematology and help secure the future of hematology research and care! Support the @ASH_hematology foundation hematology.org/foundation
Hematologists are problem-solvers. I’m proud to join my friend and colleague Dr. Belinda Avalos (@b_avalos_MD) support the #Fight4Hematology to fund bold research and training that pushes our field forward. Donate Now donate.hematology.org/s/ @ASH_hematology
At some point, someone invested in us. Now it’s our turn. Join me in supporting the #Fight4Hematology and help secure the future of hematology research and care. ASH Foundation - Hematology.org hematology.org/foundation
Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial - The Lancet Haematology thelancet.com/journals/lanha… 1. CR/CRi rate 77% in RR B-cell ALL…
So sad to hear this. High risk #MDS continues to be tough to conquer. Awaiting more results to understand this neg study.
Long awaited results of #VERONA (PH3 of aza-ven vs aza) in higher risk MDS press release with negative top line results for OS. We unfortunately remain in the dreaded boulevard of broken dreams in higher risk #MDSsm. Subgroup analyses will be important. news.abbvie.com/2025-06-16-Abb…
LENZ/AZA seems to be effective in high risk CMML enriched with CBL and RAS mutations. 85%CR mCR. GM-CSFi. #EHA25 congress-distribution.ehaweb.org/from.storage?i…
Azacitidine impact on 88 #Vexas pts ⭐️ RFS was 90% for responders ⭐️ pts had TI and ⬇️ inflammation ⭐️⭐️ response takes >6 months to happen in majority ⭐️ U A1 ⬇️VAF occurred in 65%. Some had VAF <2% #EHA25 congress-distribution.ehaweb.org/from.storage?i…
#EHA2025 #EHA25 #PPM1D #TP53 Do visit our poster, highlighting the prevalence and clinical correlates of PPM1Dm in therapy-related #clonal_hematopoiesis #clonal_cytopenia Key takeaways: 1. In one of the largest cohorts, PPM1Dm +/- TP53m were significantly enriched in therapy…
Dose attenuated ven in #AML with AZA. Single arm, nice results. #eha25 #amlsm
Large #kmt2ar AML retrospective study of outcome and characteristics. #eha25
More data on #DDX41 germline carriers and their risk to develop MN. 👏 #eha25
